34 results
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
8 Aug 22
Atossa Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
had cash, cash equivalents and restricted cash of approximately $125,647.
For the quarter ended June 30, 2022, Atossa had no source of sustainable … June 30, 2022, Atossa had no source of sustainable revenue and no associated cost of revenue.
Operating Expenses: Total operating expenses were
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
9 May 22
Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
(in thousands):
For the quarter ended March 31, 2022, Atossa has no source of sustainable revenue and no associated cost of revenue.
As of March 31
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
13 Aug 19
Atossa Genetics Announces Second Quarter 2019 Financial Results and Provides Company Update
8:33am
no source of sustainable revenue and no associated cost of revenue.
Total operating expenses were approximately $7,286,000 and $11,350,000
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
31 Mar 21
Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
9:01am
December 31, 2020, Atossa has no source of sustainable revenue and no associated cost of revenue.
Operating Expenses
Total operating expenses were
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
14 May 21
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
9:15am
, 2021 Financial Results
For the quarter ended March 31, 2021, Atossa has no source of sustainable revenue and no associated cost of revenue
8-K
EX-99.1
bjtx49ge
26 Mar 20
Atossa Therapeutics Announces Fourth Quarter and Year End 2019 Financial Results and Provides Company Update
8:05am
8-K
EX-99.1
ooh1z1e
13 May 20
Atossa Therapeutics Announces First Quarter 2020 Financial Results and Provides Company Update on COVID-19 HOPE and Endoxifen Programs
9:30am
8-K
EX-99.1
diuq0 ixy9zqoonu8741
15 Nov 21
Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
9:25am
8-K
EX-99.1
x8565
13 Nov 20
Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
9:30am
8-K
EX-99.1
gl7oqge0swz121owe9
13 Nov 19
Atossa Genetics Announces Third Quarter 2019 Financial Results and Provides Company Update
9:03am
8-K
EX-99.1
vinb18o8ufmg 5z5ml
13 Aug 20
Atossa Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:30am
8-K
EX-99.1
db5001kgowlp328
13 Aug 21
Atossa Therapeutics Announces Second Quarter 2021 Financial Results - Provides Corporate Update and Information about Upcoming Stockholder Meeting
9:30am
8-K
EX-99.1
ilovysvml5 cqw
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am